Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years T.G. Harrison, N. Doshi, N.K. Fry, C.A.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Molecular epidemiology of Legionnaires‘ disease in Israel

Molecular epidemiology of Legionnaires‘ disease in Israel

Assessment of fluorescent amplified fragment length polymorphism analysis for epidemiological genotyping of Legionella pneumophila serogroup 1 N.K. Fry,

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Legionella spp. in UK composts—a potential public health issue?

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Environmental surveillance and other control measures in the prevention of nosocomial fungal infections P. Muñoz, A. Burillo, E. Bouza Clinical Microbiology.

Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillance S.T. Chien,

Vector control: a cornerstone in the malaria elimination campaign

Assessment of fluorescent amplified fragment length polymorphism analysis for epidemiological genotyping of Legionella pneumophila serogroup 1 N.K. Fry,

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Bacterial resistance—the clinical challenge

The occurrence of Legionella species other than Legionella pneumophila in clinical and environmental samples in Denmark identified by mip gene sequencing.

Elements of design: the knowledge on which we build

Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product T.G. Bromage Clinical Microbiology.

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Extension of the Legionella pneumophila sequence-based typing scheme to include strains carrying a variant of the N-acylneuraminate cytidylyltransferase.

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Current experience in treating invasive zygomycosis with posaconazole

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

A. Ramette, J.M. Tiedje, A. Boetius

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Are we losing the fight against malaria one more time?

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Legionnaires’ disease and gardening

Enhanced isolation of Legionella species from composted material

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years T.G. Harrison, N. Doshi, N.K. Fry, C.A. Joseph Clinical Microbiology and Infection Volume 13, Issue 1, Pages 78-85 (January 2007) DOI: 10.1111/j.1469-0691.2006.01558.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Culture-confirmed cases of Legionnaires’ disease reported to the national surveillance scheme for England and Wales (1980–1998), showing the number included in this study. Clinical Microbiology and Infection 2007 13, 78-85DOI: (10.1111/j.1469-0691.2006.01558.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions